ArticleRadiology case reports2025
Transjugular ultrasound-assisted catheter direct fibrinolysis (EKOS) for relapsed IVC filter thrombosis and phlegmasia cerulea dolens.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phlegmasia cerulea dolens (PCD) is a devastating presentation of deep venous thrombosis (DVT), that may cause venous gangrene, amputation, and death. A 69-year old male presented with PCD in the lower limbs. Ultrasound (US) and CT-angiogram revealed lower extremities DVT cranially extended to iliac veins and inferior vena cava (IVC) involving an infrarenal IVC filter. In his history, there was 10 years earlier his first occurrence of filter-related PCD, which did require surgical thrombectomy. Currently, we gained access to IVC-filter thrombus from left internal jugular vein and easily placed an EKOS catheter in right femoral vein. Then we started the US-assisted fibrinolysis (EKOS) with low-dose r-TPA. Immediate overnight clinical improvement occurred and a postprocedure venography at 48 hours confirmed complete recanalization. We report the present case upon PCD to remark 2 unique features. First, we used successfully EKOS by transjugular route for PCD. EKOS combines the effectiveness of low dose r-TPA catheter direct thrombolysis (CDT) with the ultrasound's technology. The descending transjugular approach, previously unreported in this clinical setting, can reduce operative time, invasiveness and risk of filter's displacement in comparison with other thrombectomy devices used via popliteal or femoral approach. Second, we verified for the first time to the best of our knowledge the relapse of PCD in a very long time span (a decade) in the same patient underscoring the significance of vena cava filter as a powerful and persistent risk factor for IVC-thrombosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.